Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels
Hausenloy and Yellon
Heart 2008;94:706-714.
ABSTRACT
| FULL TEXT
Laboratory Assessment of HDL Heterogeneity and Function
Movva and Rader
Clin. Chem. 2008;54:788-800.
ABSTRACT
| FULL TEXT
Microvascular and Macrovascular Complications of Diabetes
Fowler
Clin. Diabetes 2008;26:77-82.
FULL TEXT
The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi and Cooper
Endocr. Rev. 2008;29:76-131.
ABSTRACT
| FULL TEXT
Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol.
deGoma et al.
J Am Coll Cardiol 2008;51:49-55.
ABSTRACT
| FULL TEXT
The sense of coherence and risk of injuries: role of alcohol consumption and occupation
Poppius et al.
J. Epidemiol. Community Health 2008;62:35-41.
ABSTRACT
| FULL TEXT
Pioglitazone and Risk of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Trials
Lincoff et al.
JAMA 2007;298:1180-1188.
ABSTRACT
| FULL TEXT
Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women
Nordestgaard et al.
JAMA 2007;298:299-308.
ABSTRACT
| FULL TEXT
Inhibition of CETP as a novel therapeutic strategy for reducing the risk of atherosclerotic disease
Shah
Eur Heart J 2007;28:5-12.
ABSTRACT
| FULL TEXT
Combined Organ Failure with Combination Antihyperlipidemic Treatment: A Case of Hepatic Injury and Acute Renal Failure
Akoglu et al.
The Annals of Pharmacotherapy 2007;41:143-147.
ABSTRACT
| FULL TEXT
Peroxisome Proliferator-Activated Receptors at the Crossroads of Obesity, Diabetes, and Cardiovascular Disease
Gilde et al.
J Am Coll Cardiol 2006;48:A24-A32.
ABSTRACT
| FULL TEXT
The gap between theory and practice: what do the trials tell us?
Pedersen
Eur Heart J Suppl 2006;8:F10-F16.
ABSTRACT
| FULL TEXT
Gemfibrozil in the Treatment of Dyslipidemia: An 18-Year Mortality Follow-up of the Helsinki Heart Study.
Tenkanen et al.
Arch Intern Med 2006;166:743-748.
ABSTRACT
| FULL TEXT
Emerging Therapies Targeting High-Density Lipoprotein Metabolism and Reverse Cholesterol Transport
Duffy and Rader
Circulation 2006;113:1140-1150.
FULL TEXT
Review: Fibrates: therapeutic review
Chapman
British Journal of Diabetes & Vascular Disease 2006;6:11-19.
ABSTRACT
Non-High-Density Lipoprotein Cholesterol and Apolipoprotein B in the Prediction of Coronary Heart Disease in Men
Pischon et al.
Circulation 2005;112:3375-3383.
ABSTRACT
| FULL TEXT
Calculating global risk: the key to intervention
Assmann
Eur Heart J Suppl 2005;7:F9-F14.
ABSTRACT
| FULL TEXT
Raising HDL-cholesterol and lowering CHD risk: does intervention work?
Shepherd
Eur Heart J Suppl 2005;7:F15-F22.
ABSTRACT
| FULL TEXT
Effects of Cholesteryl Ester Transfer Protein Inhibition on High-Density Lipoprotein Subspecies, Apolipoprotein A-I Metabolism, and Fecal Sterol Excretion
Brousseau et al.
Arterioscler. Thromb. Vasc. Bio. 2005;25:1057-1064.
ABSTRACT
| FULL TEXT
Role of nicotinic acid in raising high-density lipoprotein cholesterol (HDL-C) to reduce cardiovascular risk: an Asian/Pacific consensus: The Pan-Asian Consensus Panel On Hdl-C
Barter
British Journal of Diabetes & Vascular Disease 2005;5:S1-S15.
ABSTRACT
Phosphatidylinositol increases HDL-C levels in humans
Burgess et al.
J. Lipid Res. 2005;46:350-355.
ABSTRACT
| FULL TEXT
A Randomized Trial of a Strategy for Increasing High-Density Lipoprotein Cholesterol Levels: Effects on Progression of Coronary Heart Disease and Clinical Events
Whitney et al.
ANN INTERN MED 2005;142:95-104.
ABSTRACT
| FULL TEXT
Raising HDL-C and lowering triglycerides: benefits beyond LDL-C modification
Shepherd
British Journal of Diabetes & Vascular Disease 2005;5:S12-S16.
ABSTRACT
A review of CETP and its relation to atherosclerosis
de Grooth et al.
J. Lipid Res. 2004;45:1967-1974.
ABSTRACT
| FULL TEXT
HDL Cholesterol and Protective Factors in Atherosclerosis
Assmann and Gotto
Circulation 2004;109:III-8-III-14.
ABSTRACT
| FULL TEXT
Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study
Colquhoun et al.
Eur Heart J 2004;25:771-777.
ABSTRACT
| FULL TEXT
Effect of Levothyroxine Replacement on Lipid Profile and Intima-Media Thickness in Subclinical Hypothyroidism: A Double-Blind, Placebo- Controlled Study
Monzani et al.
J. Clin. Endocrinol. Metab. 2004;89:2099-2106.
ABSTRACT
| FULL TEXT
High-Density Lipoprotein and Cardiovascular Risk
Toth
Circulation 2004;109:1809-1812.
FULL TEXT
Effects of an Inhibitor of Cholesteryl Ester Transfer Protein on HDL Cholesterol
Brousseau et al.
NEJM 2004;350:1505-1515.
ABSTRACT
| FULL TEXT
Is high-density lipoprotein the protector of the cardiovascular system?
Barter
Eur Heart J Suppl 2004;6:A19-A22.
ABSTRACT
| FULL TEXT
Aggressive Lipid Management for Cardiovascular Prevention: Evidence from Clinical Trials
Friday
Exp. Biol. Med. 2003;228:769-778.
ABSTRACT
| FULL TEXT
Medical Management of Hyperlipidemia/Dyslipidemia
Kreisberg and Oberman
J. Clin. Endocrinol. Metab. 2003;88:2445-2461.
FULL TEXT
Review: Reconsidering the value of fibrates: lessons from the trials
Barter
British Journal of Diabetes & Vascular Disease 2003;3:162-167.
ABSTRACT
Triglyceride-Rich Lipoproteins and Vascular Function
Haynes
Arterioscler. Thromb. Vasc. Bio. 2003;23:153-155.
FULL TEXT
Haplotype analysis of the CETP gene: not TaqIB, but the closely linked -629C->A polymorphism and a novel promoter variant are independently associated with CETP concentration
Klerkx et al.
Hum Mol Genet 2003;12:111-123.
ABSTRACT
| FULL TEXT
Correlates of Serum High-Density Lipoprotein Cholesterol: A Community-Based Study of Middle-Aged and Older Men and Women in Japan
Dalei Chi et al.
Asia Pac J Public Health 2003;15:17-22.
ABSTRACT
Low-density lipoprotein lowering therapy: an analysis of the options
Sacks
J Am Coll Cardiol 2002;40:2135-2138.
FULL TEXT
Statins and stroke: evidence for cholesterol-independent effects
Di Napoli et al.
Eur Heart J 2002;23:1908-1921.
Effect of partial compliance on cardiovascular medication effectiveness
Cramer
Heart 2002;88:203-206.
FULL TEXT
Reducing cholesterol and atherosclerosis
Hornung
QJM 2002;95:339-341.
FULL TEXT
The Scientific Evidence for a Beneficial Health Relationship Between Walnuts and Coronary Heart Disease
Feldman
J. Nutr. 2002;132:1062S-1101.
ABSTRACT
| FULL TEXT
Disparities in the Diagnosis and Pharmacologic Treatment of High Serum Cholesterol by Race and Ethnicity: Data From the Third National Health and Nutrition Examination Survey
Nelson et al.
Arch Intern Med 2002;162:929-935.
ABSTRACT
| FULL TEXT
Lipoprotein Profile in Subclinical Hypothyroidism: Response to Levothyroxine Replacement, a Randomized Placebo-Controlled Study
Caraccio et al.
J. Clin. Endocrinol. Metab. 2002;87:1533-1538.
ABSTRACT
| FULL TEXT
Lipoproteins, nutrition, and heart disease
Schaefer
Am. J. Clin. Nutr. 2002;75:191-212.
ABSTRACT
| FULL TEXT
Lp A-I and Niacin: New Views of an Antiatherogenic Duo
Saucan and Brinton
Arterioscler. Thromb. Vasc. Bio. 2001;21:1707-1709.
FULL TEXT
Antioxidant Supplements Block the Response of HDL to Simvastatin-Niacin Therapy in Patients With Coronary Artery Disease and Low HDL
Cheung et al.
Arterioscler. Thromb. Vasc. Bio. 2001;21:1320-1326.
ABSTRACT
| FULL TEXT
Compliance with drug therapy--new answers to an old question
Dusing et al.
Nephrol Dial Transplant 2001;16:1317-1321.
FULL TEXT
Phase I Clinical Trial of Alitretinoin and Tamoxifen in Breast Cancer Patients: Toxicity, Pharmacokinetic, and Biomarker Evaluations
Lawrence et al.
JCO 2001;19:2754-2763.
ABSTRACT
| FULL TEXT
Treating lipids in cardiovascular disease: new directions
Wiklund
Eur Heart J Suppl 2001;3:B27-B31.
ABSTRACT
Relation of Gemfibrozil Treatment and Lipid Levels With Major Coronary Events: VA-HIT: A Randomized Controlled Trial
Robins et al.
JAMA 2001;285:1585-1591.
ABSTRACT
| FULL TEXT
The Year in Review: Cardiology
Sanoski
Journal of Pharmacy Practice 2001;14:18-40.
ABSTRACT
Introduction: Low-Saturated Fat, High-Carbohydrate Diets: Effects on Triglyceride and LDL Synthesis, the LDL Receptor, and Cardiovascular Disease Risk
Knopp
Exp. Biol. Med. 2000;225:175-177.
FULL TEXT
Weight cycling and high-density lipoprotein cholesterol in women: evidence of an adverse effect: A report from the NHLBI-sponsored WISE study
Olson et al.
J Am Coll Cardiol 2000;36:1565-1571.
ABSTRACT
| FULL TEXT
Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy
Isles and Paterson
QJM 2000;93:567-574.
ABSTRACT
| FULL TEXT
The Trouble With Triglycerides
Rubins
Arch Intern Med 2000;160:1903-1904.
FULL TEXT
Do Triglycerides Provide Meaningful Information About Heart Disease Risk?
Avins and Neuhaus
Arch Intern Med 2000;160:1937-1944.
ABSTRACT
| FULL TEXT
Association of Cholesteryl Ester Transfer Protein-TaqIB Polymorphism With Variations in Lipoprotein Subclasses and Coronary Heart Disease Risk : The Framingham Study
Ordovas et al.
Arterioscler. Thromb. Vasc. Bio. 2000;20:1323-1329.
ABSTRACT
| FULL TEXT
Extended-Release Niacin vs Gemfibrozil for the Treatment of Low Levels of High-Density Lipoprotein Cholesterol
Guyton et al.
Arch Intern Med 2000;160:1177-1184.
ABSTRACT
| FULL TEXT
How accelerated atherosclerosis in SLE has changed our management of the disorder
Hallegua and Wallace
Lupus 2000;9:228-231.
ABSTRACT
Estimating the Long-Term Effects of Storage at -70 {degrees}C on Cholesterol, Triglyceride, and HDL-Cholesterol Measurements in Stored Sera
Shih et al.
Clin. Chem. 2000;46:351-364.
ABSTRACT
| FULL TEXT
Worst Pills, Best Pills: A Consumer's Guide to Avoiding Drug-Induced Death or Illness
Raschke
JAMA 1999;282:1383-1384.
FULL TEXT
Changes in Women's Plasma Lipid and Lipoprotein Concentrations Due to Moderate Consumption of Alcohol Are Affected by Dietary Fat Level
Rumpler et al.
J. Nutr. 1999;129:1713-1717.
ABSTRACT
| FULL TEXT
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
Rubins et al.
NEJM 1999;341:410-418.
ABSTRACT
| FULL TEXT
Pleiotropy and Genotype by Diet Interaction in a Baboon Model for Atherosclerosis : A Multivariate Quantitative Genetic Analysis of HDL Subfractions in Two Dietary Environments
Mahaney et al.
Arterioscler. Thromb. Vasc. Bio. 1999;19:1134-1141.
ABSTRACT
| FULL TEXT
Ultrasound and Lipoproteins as Predictors of Lipid-Rich, Rupture-Prone Plaques in the Carotid Artery
Gronholdt
Arterioscler. Thromb. Vasc. Bio. 1999;19:2-13.
ABSTRACT
| FULL TEXT
Regular Physical Activity and Risk Factors for Coronary Heart Disease • Response
Benzer et al.
Circulation 1998;98:2356-2356.
FULL TEXT
Perspectives in the Treatment of Dyslipidemias in the Prevention of Coronary Heart Disease
Borgia and Medici
ANGIOLOGY 1998;49:339-348.
ABSTRACT
Influence of Pravastatin and Plasma Lipids on Clinical Events in the West of Scotland Coronary Prevention Study (WOSCOPS)
Circulation 1998;97:1440-1445.
ABSTRACT
| FULL TEXT
Relationship Between Plasma LDL Concentrations During Treatment With Pravastatin and Recurrent Coronary Events in the Cholesterol and Recurrent Events Trial
Sacks et al.
Circulation 1998;97:1446-1452.
ABSTRACT
| FULL TEXT
Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S)
Pedersen et al.
Circulation 1998;97:1453-1460.
ABSTRACT
| FULL TEXT
Estimating the Benefits of Modifying Risk Factors of Cardiovascular Disease: A Comparison of Primary vs Secondary Prevention
Grover et al.
Arch Intern Med 1998;158:655-662.
ABSTRACT
| FULL TEXT
Treating Hyperlipidemia for the Primary Prevention of Coronary Disease: Are Higher Dosages of Lovastatin Cost-effective?
Perreault et al.
Arch Intern Med 1998;158:375-381.
ABSTRACT
| FULL TEXT
Echo-Lucency of Computerized Ultrasound Images of Carotid Atherosclerotic Plaques Are Associated With Increased Levels of Triglyceride-Rich Lipoproteins as Well as Increased Plaque Lipid Content
Gronholdt et al.
Circulation 1998;97:34-40.
ABSTRACT
| FULL TEXT
Upregulation of Low Density Lipoprotein Receptor by Gemfibrozil, a Hypolipidemic Agent, in Human Hepatoma Cells Through Stabilization of mRNA Transcripts
Goto et al.
Arterioscler. Thromb. Vasc. Bio. 1997;17:2707-2712.
ABSTRACT
| FULL TEXT
Prevention of the Angiographic Progression of Coronary and Vein-Graft Atherosclerosis by Gemfibrozil After Coronary Bypass Surgery in Men With Low Levels of HDL Cholesterol
Frick et al.
Circulation 1997;96:2137-2143.
ABSTRACT
| FULL TEXT
Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis
Munro et al.
Ann Rheum Dis 1997;56:374-377.
ABSTRACT
| FULL TEXT
Nonhypercholesterolemic Effects of a Palm Oil Diet in Chinese Adults
Zhang et al.
J. Nutr. 1997;127:509-509.
ABSTRACT
| FULL TEXT
Attenuation by Gemfibrozil of Expression of Plasminogen Activator Inhibitor Type 1 Induced by Insulin and its Precursors
Nordt et al.
Circulation 1997;95:677-683.
ABSTRACT
| FULL TEXT
Echolucent Carotid Artery Plaques Are Associated With Elevated Levels of Fasting and Postprandial Triglyceride-Rich Lipoproteins
Gronholdt et al.
Stroke 1996;27:2166-2172.
ABSTRACT
| FULL TEXT
Effects of 1 Year of Growth Hormone Therapy on Serum Lipoprotein Levels in Growth Hormone–Deficient Adults : Influence of Gender and Apo(a) and ApoE Phenotypes
Johannsson et al.
Arterioscler. Thromb. Vasc. Bio. 1995;15:2142-2150.
ABSTRACT
| FULL TEXT
A Prospective, Randomized Trial of Phenytoin in Nonepileptic Subjects With Reduced HDL Cholesterol
Miller et al.
Arterioscler. Thromb. Vasc. Bio. 1995;15:2151-2156.
ABSTRACT
| FULL TEXT
Plasma HDL Cholesterol, Triglycerides, and Adiposity : A Quantitative Genetic Test of the Conjoint Trait Hypothesis in the San Antonio Family Heart Study
Mahaney et al.
Circulation 1995;92:3240-3248.
ABSTRACT
| FULL TEXT
A Major Locus Influencing Plasma High-Density Lipoprotein Cholesterol Levels in the San Antonio Family Heart Study : Segregation and Linkage Analyses
Mahaney et al.
Arterioscler. Thromb. Vasc. Bio. 1995;15:1730-1739.
ABSTRACT
| FULL TEXT
Attenuation of the Synthesis of Plasminogen Activator Inhibitor Type 1 by Niacin : A Potential Link Between Lipid Lowering and Fibrinolysis
Brown et al.
Circulation 1995;92:767-772.
ABSTRACT
| FULL TEXT
Cholesterol Reduction in Cardiovascular Disease -- Clinical Benefits and Possible Mechanisms
Levine et al.
NEJM 1995;332:512-521.
FULL TEXT
Effects of Alcohol Consumption on Lipoproteins of Premenopausal Women : A Controlled Diet Study
Clevidence et al.
Arterioscler. Thromb. Vasc. Bio. 1995;15:179-184.
ABSTRACT
| FULL TEXT
Antihypertensive Therapy in Dyslipidemic Men : Effects on Coronary Heart Disease Incidence and Total Mortality
Manttari et al.
Hypertension 1995;25:47-52.
ABSTRACT
| FULL TEXT
Possibly Disappointing Results of Treatment with Gemfibrozil
Newman et al.
NEJM 1993;328:139-140.
FULL TEXT
. Hyperlipidemia as a Complication of Niemann-Pick Type B Disease
Filling-Katz et al.
CLIN PEDIATR 1990;29:670-673.
Efficacy and Safety of a Novel Cholesteryl Ester Transfer Protein Inhibitor, JTT-705, in Humans: A Randomized Phase II Dose-Response Study
de Grooth et al.
Circulation 2002;105:2159-2165.
ABSTRACT
| FULL TEXT
